Absci Corporation Registered Shs Aktie

Absci Corporation Registered Shs für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A3CVW3 / ISIN: US00091E1091

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
25.07.2025 23:16:41

Absci Prices $50 Mln Public Offering To Advance AI-Driven Drug Programs

(RTTNews) - Absci Corporation (ABSI), a clinical-stage biopharma company leveraging generative AI for drug discovery, has priced an underwritten public offering of 16.67 million shares of its common stock at $3.00 per share.

The offering is expected to generate approximately $50 million in gross proceeds, excluding any additional funds from the underwriters' 30-day option to purchase up to 2.5 million more shares on the same terms.

All shares in the offering will be sold by Absci. Net proceeds will support the company's internal pipeline, further development of its Integrated Drug Creation platform, and general corporate purposes.

The offering is expected to close around July 25, 2025, pending customary conditions.

ABSI currently trades at $2.855 or 18.6610% lower on the NasdaqGS.

Analysen zu Absci Corporation Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Absci Corporation Registered Shs 3,38 -4,79% Absci Corporation Registered Shs